MOESM3 of FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures

Additional file 3. Table S1. Summary of artifact signatures in publicly available callsets, Table S2. FIREVAT VCF attribute usage and configuration by callset on the mc3 performance validation dataset, Table S3. MC3 performance validation dataset samples, Table S4. FIREVAT performance summary on the mc3 performance validation dataset, Table S5. FIREVAT performance on the mc3 performance validation dataset, Table S6 and S7. FIREVAT refinement on the multi-region whole-exome sequencing of breast cancer dataset, Table S8. TCGA-HNSC dataset before and after firevat refinement, Table S9. TCGA platinum therapy response dataset before and after FIREVAT refinement, Table S10. Characteristics of artifactual variants identified by FIREVAT in publicly available VCF callsets.